Lord's Mark Industries Limited has intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.
Lord's Mark showcased defence products from its investee Brahamastra, including BRAK RT and TRC-1. The promotional release discloses no orders, revenue, or quantified investment amount.
Lord's Mark Industries seeks approval for a promoter loan of up to ₹100 Crore convertible into equity via postal ballot. E-voting closes November 25, 2026.
Lord's Mark Industries approved a ₹100 Crore convertible loan from promoter MD Upadhyay. Shareholder approval will be sought via postal ballot by November 27, 2026.
Lord’s Mark Industries completed its Silvassa manufacturing capacity expansion ahead of schedule. The company also secured US FDA registration for over 200 surgical and hygiene products.
Lord's Mark Industries will hold a board meeting on October 23, 2026, to consider raising a Rs. 100 Crore unsecured convertible loan from its promoter.
Lord's Mark Industries acquired 100% equity in Radio Electric Private Limited for ₹4.50 Crore. This acquisition strengthens its Lighting & Energy Division with established manufacturing capabilities.
Lord's Mark Industries Limited has acquired Radio Electric Private Limited, the owner of the 'Radiotone' brand, to expand its electrical manufacturing and engineering capabilities.
Lords Mark Industries Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b), disclosing promoter and public shareholding distribution as of September 30, 2026.
Lord’s Mark Industries received MHRA registration for its IVD portfolio, enabling UK commercial sales from December 2026. The milestone supports its international healthcare expansion strategy.
Promoter Sachidanand Hariram Upadhyay sold 89,98,598 shares for Rs. 76.18 Crore through the open market. The proceeds will be reinvested into expanding the company's medical device unit.
Promoter Sachidanand Hariram Upadhyay sold 89,98,598 shares (2.11% stake) of Lords Mark Industries Limited via open market. The promoter's holding decreased to 73.00%.
Lords Mark Industries Ltd held its 46th AGM on September 30, 2026. Shareholders transacted ordinary and special business, including director appointments and approving borrowing limits.
Lords Mark Industries Ltd has appointed new Secretarial, Statutory, and Cost Auditors. These are routine auditor appointments reported via an XBRL filing.
Lord’s Mark Industries has advanced its AI-powered breast cancer screening technology to final clinical trial stages. The company targets a global commercial launch by April 2027.
Lord's Mark Industries is a MedTech and Renewable Energy conglomerate focused on high-margin diagnostic innovations and a ₹3,000+ Cr solar order pipeline.
Lord's Mark Industries Limited has filed its 46th Annual Report for the financial year 2025-26 and the notice of its upcoming 46th Annual General Meeting.
Lords Mark Industries entered a strategic partnership with ARKALL Holdings for Caribbean healthcare expansion. The collaboration targets $100 million in export revenue from diagnostic and medical device commercialisation.
Lords Mark Industries reported Q1 FY27 results, achieving 280 Cr topline and 32 Cr bottom line. The firm is transitioning from traditional energy to high-margin MedTech and diagnostics.
Infomerics upgraded Lord's Mark Industries Limited's credit rating to IVR A-/Stable for long-term and IVR A2+ for short-term bank facilities totaling Rs. 260.37 Crore.
Lord's Mark Industries Limited scheduled its 46th Annual General Meeting for September 30, 2026. The company set September 23, 2026, as the cut-off date for e-voting.
Lord’s Mark Industries announced a major strategic expansion including a demerger of its energy business, incorporation of UK and Swiss subsidiaries, and the establishment of 50 dialysis centres.